What is the IV dose equivalence of Ativan (lorazepam) to Versed (midazolam) in adults, and how should the dose be adjusted for elderly or patients with hepatic impairment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lorazepam to Midazolam IV Dose Equivalence

Lorazepam is twice as potent as midazolam, meaning 1 mg of IV lorazepam equals approximately 2 mg of IV midazolam. 1

Conversion Formula

To convert from midazolam to lorazepam: divide the 24-hour midazolam dose by 12 (accounting for lorazepam being twice as potent and having a sixfold longer half-life). 1

To convert from lorazepam to midazolam: multiply the lorazepam dose by 2 for equipotent effect, though you must account for the dramatically different half-lives when determining dosing frequency. 1

Practical Dosing Examples

  • For procedural sedation: If using midazolam 2-5 mg IV initially, the equivalent lorazepam dose would be 1-2.5 mg IV. 2, 3

  • For acute agitation: Midazolam 2.5-5 mg IV/SC equals lorazepam 1.25-2.5 mg IV/SC. 3

  • For continuous infusion conversion: A midazolam infusion of 2.4 mg/hour (approximately 0.05 mg/kg/hr for a 50 kg patient) would convert to lorazepam 0.2 mg/hour when accounting for both potency difference and half-life. 1, 2

Critical Dose Adjustments Required

Elderly Patients (≥60 years)

Reduce both medications by at least 50% in elderly patients due to pharmacodynamic alterations, not pharmacokinetic changes. 2, 3, 4

  • Midazolam: Use 0.5-1 mg IV maximum per dose instead of standard 2-5 mg. 2, 3
  • Lorazepam: Use 0.25-0.5 mg IV maximum per dose instead of standard 1-2.5 mg. 3, 5

Hepatic Impairment

Lorazepam is the safer choice in liver disease because it undergoes only glucuronidation, while midazolam requires hepatic oxidation which is significantly impaired in liver disease. 6

  • Midazolam: Reduce dose by at least 20-30% in hepatic impairment due to reduced clearance and risk of accumulation. 2
  • Lorazepam: Minimal dose adjustment needed as glucuronidation is preserved even in advanced liver disease, making it the preferred benzodiazepine in this population. 6

Renal Impairment

Both medications require dose reduction of at least 20% in renal impairment, though lorazepam remains safer due to its simpler metabolism. 2, 6

Concurrent Opioid Use

Reduce both benzodiazepine doses by at least 20-30% when combined with opioids due to synergistic respiratory depression. 2, 3

  • The combination of midazolam and fentanyl caused hypoxemia in 92% of volunteers versus 50% with fentanyl alone and 0% with midazolam alone. 2

Pharmacokinetic Differences That Matter Clinically

Midazolam has rapid onset (1-2 minutes) with peak effect at 3-4 minutes and short duration (15-80 minutes), requiring more frequent dosing. 7, 8

Lorazepam has slower onset but longer duration of action, making it unsuitable for outpatient procedures and best reserved for patients requiring sustained effect over 24-72 hours. 5

Midazolam accumulates in skeletal muscle and adipose tissue with repeated dosing, causing delayed awakening after prolonged infusions. 2

Common Pitfalls to Avoid

  • Do not use simple 2:1 conversion without accounting for half-life differences when converting continuous infusions—the 12-fold correction factor is essential. 1

  • Respiratory depression can occur up to 30 minutes after midazolam administration, requiring extended monitoring even after apparent recovery. 2, 7

  • Flumazenil's short half-life (0.7-1.3 hours) means re-sedation can occur after initial reversal, necessitating continued observation. 2, 7

  • Never combine full doses of both benzodiazepines and opioids—always reduce both agents when using combination therapy. 2

  • Lorazepam should not be used in outpatients or those with expected hospital stays less than 72 hours due to its prolonged duration of action. 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Midazolam Dosing and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Midazolam Dosing for Agitation in Psychiatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical pharmacology of lorazepam.

Contemporary anesthesia practice, 1983

Guideline

Benzodiazepine Conversion and Sedation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.